Product Information
Mounjaro Tirzepatide Injection 2.5mg/0.5mL is a cutting-edge medication designed to improve glycemic control in adults diagnosed with Type 2 Diabetes. It is a once-weekly subcutaneous injection that combines the benefits of two incretin hormones GIP and GLP-1. By activating both these receptors, Mounjaro helps the body release more insulin when blood sugar is high, reduces glucose production in the liver, slows digestion, and suppresses appetite.
This medication is typically introduced at a starting dose of 2.5mg to help the body adjust before increasing to higher therapeutic levels. Clinical trials have shown significant improvement in blood sugar levels and considerable weight loss benefits, making it a dual-purpose therapy for managing diabetes and reducing obesity-related complications.
Mounjaro is prescribed by healthcare professionals including diabetologists and endocrinologists and is used alongside a proper diet and regular exercise. It is not intended for individuals with Type 1 Diabetes or those with a history of pancreatitis. Regular monitoring of blood glucose levels and periodic consultations with a physician are recommended for safe and effective use.
Key Benefits:
Helps control high blood sugar in adults with Type 2 Diabetes
Supports long-term weight management
Improves insulin sensitivity and reduces appetite
Starting dose for a gradual and safe treatment approach
Administered once weekly via prefilled injection pen
